Genomind's Series A Round

Genomind raised a round of funding on April 09, 2014. Investors include Claritas Capital.

Genomind is a personalized medicine company, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsy…

Articles about Genomind's Series A Round: